Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Hair loss may increase heart disease risk.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Upadacitinib may cause hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Baricitinib is a promising treatment for alopecia areata.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Certain DNA regions in alpacas are linked to fiber diameter.

N1-acetylspermidine promotes hair follicle stem cell self-renewal.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Activating Tgr5 may help treat hair loss and bone loss.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Both HLA-B and MICA are independently linked to alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

People with alopecia areata have higher insulin resistance.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

New mutations in the hairless gene may cause hair loss and affect bone development.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Human keratinocytes do not naturally respond to androgens.